Treatments & Drugs
Metabolic Syndrome Linked to Accelerated Brain Aging: New Study Reveals
New research from the U.K. Biobank reveals that metabolic syndrome significantly accelerates brain aging, offering potential pathways for preventative care.
Treatments & Drugs News
FDA drug approvals, clinical trials, and progressive medical treatments.
Treatments & Drugs
Medical Breakthroughs: Reducing Hospital Infections and Optimizing Cancer Care
Explore the latest medical advancements, from declining U.S. hospital infection rates to improved diagnostic algorithms for pulmonary embolism in cancer patients.
Treatments & Drugs
Chronic Stress Hormone Levels Linked to Rapid Cognitive Decline in Seniors
A new study reveals that cumulative physiologic stress, measured through salivary cortisol, is a significant predictor of faster cognitive decline in older adults.
Treatments & Drugs
Revolutionary Alzheimer’s Blood Test Empowers Primary Care Doctors to Diagnose Faster
New research shows Alzheimer's blood tests boost primary care diagnostic accuracy to 88%, helping doctors make better clinical decisions for patients.
Treatments & Drugs
Measles Resurgence Triggers Severe Brain Swelling and Sepsis Cases Across the U.S.
Recent data from Utah and South Carolina reveal alarming rates of encephalitis and sepsis in unvaccinated measles patients. Read the latest health findings.
Treatments & Drugs
Hypoglossal Nerve Stimulation: Long-Term Heart Health Benefits vs. Early Risks
A new study reveals that while hypoglossal nerve stimulation for sleep apnea offers long-term heart benefits, it carries unexpected early-stage cardiovascular risks.
Treatments & Drugs
Revolutionary Blood Test Predicts Alzheimer’s Risk a Decade Before Symptoms Appear
A breakthrough blood test measuring p-tau217 levels can predict Alzheimer's-related cognitive decline up to 10 years early, offering new hope for prevention.
Treatments & Drugs
Cannabis Breakthrough: New Treatment Dramatically Reduces Agitation in Dementia Patients
A phase II trial reveals that a specific THC-CBD combination significantly reduces agitation in hospice-eligible dementia patients, offering new hope for care.
Treatments & Drugs
Tau-Targeting Breakthrough: Diranersen Shows Cognitive Promise in Alzheimer's Fight
New phase II clinical trial results for diranersen reveal promising cognitive benefits and tau reduction in early-stage Alzheimer's disease patients.
Treatments & Drugs
Medical Alerts: GLP-1 Eye Risks, Tylenol Lawsuit Revival, and Emerging Outbreaks
Stay informed on the latest medical news, including new GLP-1 eye risks, the revival of Tylenol-autism litigation, and critical public health outbreaks.
Treatments & Drugs
FDA Greenlights At-Home Alzheimer’s Treatment: A Paradigm Shift for Patients
The FDA has approved a new at-home subcutaneous starting dose for lecanemab, allowing Alzheimer's patients to begin treatment outside of clinical settings.
Treatments & Drugs
Beat the Clock: Lifestyle Shifts Before 70 May Shield Your Brain from Aging
New POINTER trial data reveals that structured lifestyle interventions can slow brain white matter aging in adults under 70, offering a path to cognitive health.